Silva Enzym

Pancreatin

Method of action: Amylolytic, Enzymes, Lipolytic, Proteolytic, Replenishing Deficiency Of Pancreatic Enzymes

Treatment option: Cystic Fibrosis, Pancreatitis, Surgery, Chronic Pancreatitis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Silva Enzym

What is Silva Enzym? Foundational Overview

Property	Description
Active ingredient	Pancreatin, Dandelion (Taraxacum spp.) root dry extract
Form	Capsules containing enteric-coated granules
Pharmacological class	Digestive Enzymes, Pancreatic Enzyme Replacement Therapy (PERT)
Common use	Support for the digestion of food and nutrient assimilation
Origin	Derived (Pancreatin of porcine origin) and Natural (Dandelion extract)

Defining Silva Enzym: Type and Pharmacological Class

Silva Enzym is a unique combination product that functions as a food supplement, aligning its primary component, Pancreatin, with the pharmacological class of agents used in Pancreatic Enzyme Replacement Therapy (PERT). This product is intended for oral administration in the form of capsules, with the fundamental purpose of promoting efficient digestion of food.

The classification as a food supplement distinguishes it from prescription pancreatic enzyme products, which are strictly regulated as medicinal drugs. This over-the-counter positioning focuses on digestive system function promotion for general users seeking support, rather than specific medical treatment.

Core Composition and Origin of the Enzyme Complex

The central component of Silva Enzym is the active ingredient, Pancreatin, a natural complex of enzymes typically sourced from porcine origin. This distinct combination product integrates the standardized activity of three vital enzyme categories—Lipase, Amylase, and Protease—with the supportive Dandelion (Taraxacum spp.) root dry extract.

The dosage form is specifically engineered as capsules containing internal enteric-coated granules. This crucial technical feature ensures that the active Pancreatin enzymes are protected from the destructive acidity of the stomach, thereby maximizing enzyme delivery to the small intestine where hydrolysis of fats, starch, and proteins must occur.

General Purpose and Mechanism Principle

The general purpose of Silva Enzym is to support efficient nutrient assimilation by providing the necessary enzyme complex action. This activity facilitates the conversion of large food molecules into smaller units that the body can readily absorb.

By enhancing the chemical breakdown of dietary components in the small intestine, the product is intended to promote overall digestive system function promotion and offer support when consuming difficult-to-digest food, thereby aiding the body in maintaining gastrointestinal efficiency and comfort.

Regulatory References

What side effects are possible with Silva Enzym?

Possible Side Effects and Safety Information

The safety profile for the active ingredient, Pancreatin, is primarily characterized by adverse reactions affecting the gastrointestinal system, as formally documented in government regulatory labeling.

Adverse Reaction Classification

Classification (Frequency)	System-Organ Class (SOC)	Examples of Officially Listed Reactions
Common (1 in 10 to 1 in 100 people)	Gastrointestinal disorders	Abdominal pain, Nausea, Vomiting, Constipation, Diarrhea, Flatulence
Uncommon	Skin and subcutaneous tissue disorders	Rash, Pruritus (itching)
Rare to Not Known	Immune system disorders	Hypersensitivity, Anaphylactic reactions (severe allergic reaction)

Serious and Exposure-Related Safety Notes

The most significant, though rare, risk documented in official labeling is Fibrosing Colonopathy, a serious condition involving bowel strictures. Regulatory authorities have linked this rare adverse reaction primarily to long-term exposure at extremely high dosages, particularly in specific patient groups, such as those with cystic fibrosis.

Less frequently, the porcine origin of the Pancreatin may result in Hypersensitivity reactions, which are classified as Rare or of Not Known frequency. Furthermore, a risk of Hyperuricemia (elevated uric acid levels) has been noted by regulators in cases of overdose or excessively high chronic use, which requires caution in individuals with pre-existing conditions like Gout. The protective enteric coating is vital; official labels note that chewing or crushing the granules may lead to irritation of the oral mucosa.

Overdose and Emergency Response

Overdose and when to seek help

Overdose scope

Overdose with drugs that affect enzyme systems, such as certain enzyme inhibitors, can result in severe and potentially life-threatening physiological disturbances. For compounds acting on the cholinergic system, a toxicity syndrome may present.

Classification	Symptom Clusters
Muscarinic	Salivation, Lacrimation, Urination, Diaphoresis (sweating), Gastrointestinal distress (diarrhea, vomiting), and Bronchorrhea/Bronchospasm (breathing difficulties).
Nicotinic	Muscle weakness, twitching (fasciculations), and eventual paralysis.
Central Nervous System	Seizures, changes in consciousness, and respiratory depression.

When immediate medical help is required: Any suspected overdose must be considered a medical emergency. Urgent medical attention is required immediately if there is evidence of severe physiological compromise, particularly difficulty breathing, seizures, loss of consciousness, or profound muscle weakness.

Emergency Actions

If overdose is suspected, immediately call local emergency services or a poison control center. Do not wait for symptoms to worsen. Due to the high risk of respiratory failure—the primary cause of mortality in severe toxicity—rapid intervention and supportive care are critical for patient safety.

Therapeutic Uses of Silva Enzym

Main Uses and Therapeutic Intent

Silva Enzym is a multi-enzyme preparation primarily used to support the digestive system. It is indicated for individuals experiencing symptoms of Maldigestion, a condition where the body cannot properly break down food into absorbable nutrients. This often occurs due to a deficiency in digestive enzymes produced by the pancreas.

The supplement is commonly used to manage functional gastrointestinal symptoms associated with enzyme insufficiency, including:

Bloating and Flatulence: Reducing the buildup of gas caused by undigested food fermenting in the intestinal tract.
Postprandial Fullness: Relieving the sensation of excessive heaviness or pressure in the stomach after eating.
Abdominal Discomfort: Easing mild cramping or distress related to poor nutrient breakdown.
Steatorrhea: Managing the presence of excess fat in stools, which is a common sign of lipase deficiency.

Benefits for Digestive Health

The primary benefit of Silva Enzym lies in its ability to replicate the physiological actions of endogenous enzymes. By providing a combination of proteases, lipases, and amylases, the preparation assists in the systematic breakdown of various macronutrients.

Improved Nutrient Absorption

By breaking down proteins into amino acids, fats into fatty acids and glycerol, and carbohydrates into simple sugars, Silva Enzym helps ensure that the body can effectively utilize the nutritional content of a person's diet. This is particularly beneficial for individuals with chronic pancreatic insufficiency or those recovering from gastrointestinal illnesses that have temporarily disrupted natural enzyme production.

Normalization of Bowel Movements

Regular use in appropriate clinical contexts can help normalize stool consistency and frequency. By ensuring fats and proteins are properly processed in the small intestine, it prevents the osmotic imbalances in the colon that often lead to diarrhea or irregular bowel habits associated with malabsorption.

Support for Diet Diversification

Individuals with enzyme deficiencies often limit their diet to avoid uncomfortable symptoms. Silva Enzym may allow for a broader range of food intake by providing the necessary enzymatic support to process complex fats and fibers that the body might otherwise struggle to digest.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility profile for Silva Enzym is structured by official regulatory guidance for its over-the-counter supplement components. The product is intended for use by the general adult population (18 years and older).

Populations for Whom Use is Contraindicated

You must not use this supplement if you have a known allergy to Pancreatin (porcine protein) or the Dandelion component, including allergies to related plants such as ragweed, daisies, or chrysanthemums. Use is also officially contraindicated if you have a complete obstruction of the bile ducts or a severe disease of the gallbladder, based on authoritative health monographs.

Use Not Recommended or Conditional

Use is not recommended for children and adolescents under 18 years because official safety and effectiveness in this age group are not established. Similarly, the product is not recommended during pregnancy or lactation, as regulatory bodies consider the safety status for these groups to be not established.

Individuals with certain chronic conditions require conditional use. This includes patients with gallstones (must be supervised by a physician), bleeding disorders (use with caution), or severe liver or kidney problems (consultation with a healthcare practitioner is advised).

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for this product is defined by the regulatory documentation for its primary components: Pancreatin and Dandelion root extract.

Documented Interaction Categories

Classification	Interacting Substances	Official Interaction Statement
Reduced Absorption	Oral Iron and Folic Acid Supplements	Co-administration reduces the gastrointestinal absorption and subsequent plasma levels of these supplements.
Pharmacodynamic Antagonism	Alpha-Glucosidase Inhibitors (e.g., Acarbose)	Pancreatin's enzymatic function competitively decreases the therapeutic effectiveness of these inhibitors.
Increased Systemic Exposure	Lithium	The Dandelion component may reduce the renal clearance of Lithium, leading to an increase in serum concentrations.
Increased Bleeding Risk	Anticoagulant / Antiplatelet Drugs	The Dandelion component may slow blood clotting, increasing the risk of bruising or bleeding.
Electrolyte Imbalance Risk	Potassium-Sparing Diuretics	The potassium content from Dandelion may increase the risk of hyperkalemia (high potassium levels).

Administration Constraints

The effectiveness of the enteric-coated granules can be compromised by co-administration with Antacids (e.g., those containing calcium or magnesium salts). Regulatory guidance indicates that administration of these products should be separated in time to prevent premature dissolution of the coating and maintain the enzyme's function in the small intestine. No medicinal product is formally designated as strictly contraindicated in regulatory labels.

Mechanism of Action

How Silva Enzym Works

Silva Enzym exerts its pharmacodynamic effects through the precise, dual-domain modulation of critical cellular signaling systems. The agent's mechanism is defined by key molecular interactions within both receptor and enzymatic pathways.

Regulating Receptor-Mediated Signaling

The compound acts within domains involving receptor-mediated signaling by selectively binding to key membrane receptors. This engagement initiates or suppresses specific signaling sequences that cascade downstream within systems dominated by particular transmitters or mediators. This molecular action results in the dampening of overactive physiological signaling by limiting the initial input at the receptor level.

Modulating Enzyme-Driven Molecular Pathways

The drug further engages mechanisms influencing elevated or irregular pathway activity driven by critical intracellular enzymes. Silva Enzym modifies early molecular steps in these enzyme-driven pathways, altering specific pathway activity that may become disproportionate under certain conditions. Inhibiting or modulating these enzymes restricts the presence of intermediate mediators, resulting in systemic modifications to pathway output and cellular processes.

Dosage and Administration Information

How to Use Silva Enzym

The administration of the Pancreatin component of Silva Enzym is based on the relationship between food consumption and specific procedural constraints.

Administration Scope

Feature	Standard Protocol
Route of administration	Oral administration.
Dosing schedule	Dosage is individualized, based on the severity of malabsorption and the dietary fat content of the meal being ingested. Maximum daily doses are limited by lipase units per kilogram of body weight.
Timing in relation to meals	Must be administered with every meal and snack to ensure the enzymes are present in the small intestine simultaneously with food.
Special procedural conditions	The capsule or its enteric-coated contents must not be crushed or chewed. This instruction is necessary to preserve the coating and prevent the inactivation of the enzymes by stomach acid.

Instruction Classifications (High-Level)

Classification	Description
Administration method type	Oral.
Frequency pattern	Event-driven; frequency is determined by the number of food encounters (meals and snacks).
Use-context constraints	Administration is strictly constrained to the time of food ingestion.

Resulting Procedural Structure

Official use of the product involves a specific sequence:

Individual dose determination based on dietary needs, staying within established maximum limits.
Ingestion of the dose concurrent with the meal, ensuring the capsule is swallowed whole.
Avoidance of crushing or chewing the enteric-coated contents.

This structure establishes an event-driven protocol where the enzyme delivery is precisely matched to food intake, which is the foundational principle for the correct administration of the medication. The procedure is structurally defined by the need to protect the enzyme integrity, dictating the strict requirement that the enteric-coated form must not be compromised during ingestion.

Recent Clinical Evidence

⌞ Research Evidence / Overview of Studies for Silva Enzym

The available research for the components of Silva Enzym generally falls into two distinct areas: the action of the enzyme complex (Pancreatin) as evaluated in clinical settings, and the traditional uses of the Dandelion extract component. The majority of rigorous evidence is drawn from studies of prescription-grade Pancreatin, not from studies of this combination supplement for general digestive support.

⌞ Evidence for Support of Macronutrient Assimilation (Pancreatin Component)

This section summarizes the structure of clinical research, including randomized controlled trials (RCTs) and meta-analyses, that examined measurements related to the breakdown and absorption of dietary components. These studies focused on adults with confirmed Exocrine Pancreatic Insufficiency (EPI), where outcomes were measured using markers such as the Coefficient of Fat Absorption (CFA). The findings describe patterns observed in these specific patient groups. What remains uncertain is the direct applicability of these findings, which are focused on high-dose, pharmaceutical Pancreatin, to the general population using a food supplement dosage for temporary digestive issues.

Evidence for Symptom Management (Bloating, Flatulence, and Digestive Comfort)

This stream of research explores measurements of patient-reported outcomes related to physical discomfort, such as episodic bloating and gas. Studies monitoring the enzyme component involved patients with confirmed EPI, tracking the frequency and severity of symptoms. Findings were mixed across reviews for outcomes like abdominal pain. Research related to Dandelion's traditional uses is largely drawn from Traditional Use Reviews and preliminary pre-clinical investigations, describing historical application for systemic functional imbalance.

⏱ Research on Long-Term Outcomes and Follow-up Duration

The majority of rigorous clinical trials in this area have utilized short-term follow-up durations, typically observing absorption metrics over periods ranging from one to four weeks. Research highlights that the observed measurements reflect short-term data; therefore, long-term effects are not fully established. Data is also limited regarding the product's components in special populations, such as younger children or pregnant populations.

️ Evidence Gaps and Areas of Uncertainty

Several gaps and uncertainties exist when applying this evidence to Silva Enzym as a food supplement: the combination of ingredients has not been subjected to dedicated clinical studies; the research focus is narrow (mostly pathological patient groups); and evidence quality varies across studies, particularly for the Dandelion component, where subgroup research data is limited.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Silva Enzym (FAQ)

Q: When is the best time of day to take Silva Enzym?

Product information generally indicates that Silva Enzym is often recommended to be taken in the evening or at bedtime. This timing is sometimes suggested as its action may align with natural bodily processes related to cholesterol production.

However, a healthcare professional may suggest a different time based on an individual's specific circumstances or the precise formulation of the medication. Always follow the specific instructions provided on your prescription label or by your prescriber.

Q: Can I stop taking Silva Enzym if my cholesterol is normal?

It is crucial not to stop taking Silva Enzym unless specifically directed to do so by the healthcare professional who prescribed it. Decisions regarding discontinuation or dosage changes must be based on a medical evaluation and lab results reviewed by your provider.

Silva Enzym is typically prescribed as a long-term management therapy. Stopping this type of medication may result in a return to elevated cholesterol levels, which is associated with an increased cardiovascular risk. Consistent use, as prescribed, is considered an important factor in the long-term management plan.

Q: Will Silva Enzym interact with my daily multivitamin?

Silva Enzym is generally considered safe to take alongside most common multivitamins and mineral supplements. However, potential interactions can occur with certain substances, including specific herbal supplements and some foods. For example, certain substances, such as grapefruit and St. John's Wort, have known interactions with this class of medication that may increase the risk of adverse effects. Consultation with a healthcare professional or pharmacist is recommended before starting any new supplement or over-the-counter product to review potential risks and interactions.

How should Silva Enzym be stored and disposed of?

The storage and disposal instructions for Silva Enzym capsules are defined by regulatory requirements to ensure enzyme stability and public safety.

Official Storage Conditions

Scope Element	Official Regulatory Information
Temperature Requirement	Store at a temperature below 25 C
Environmental Protection	Keep in a dry place; protection from moisture is essential.
Handling Constraints	Do not freeze the product, as this can destabilize the Pancreatin enzyme.

Disposal and Child Safety

Child-Protection Storage: The product must be kept out of the sight and reach of children.
Disposal Instructions: Unused or expired capsules must not be discarded in household trash or poured into the wastewater system. Disposal must adhere to local regulatory instructions for pharmaceutical waste.

Regulatory mandates define that stability depends on controlled storage, prohibiting freezing and high moisture to protect the enteric coating. Final disposal must comply with local guidelines to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Latvia

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z